Latest Breaking News On - Salute san raffaele university - Page 1 : comparemela.com

The H5n1 virus epidemic is already more widespread than previously thought : what we know

The H5n1 virus epidemic is already more widespread than previously thought : what we know
thevermilion.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thevermilion.com Daily Mail and Mail on Sunday newspapers.

Baylor college of medicineUnited statesRepublic ofGianni rezzaBaylor collegeMinistry of healthSalute san raffaele universityHealth preventionAmerican centers for diseaseEuropean centerEuropean food safety authorityAmerican centersDisease controlDisease preventionVita salute san raffaele universityDirector general

Epigenetic silencing lasts in mice, Chroma-sponsored study shows

Epigenetic silencing lasts in mice, Chroma-sponsored study shows
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Angelo lombardoSalute san raffaele universityFierce biotech researchChroma medicineVita salute san raffaele universityTune therapeutics

CatalYm Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists

CatalYm Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAndrea necchiRoys herbstPhil lhuillierRoy herbstPetros grivasRoy baynesCornell university medical collegeUniversity of milanNational cancer institute thoracic malignancy steering committeeUniversity of washingtonTranslational researchUniversity of witwatersrandResearch foundationUniversity of texas md anderson cancer centerMerck research laboratories

Dr Necchi on the Efficacy of TAR-200 Monotherapy in BCG-Unresponsive NMIBC

Andrea Necchi, MD, discusses results from the phase 2b SunRISe-1 trial of TAR-200 in patients with Bacillus Calmette-Guérin (BCG)–unresponsive, high-risk, non–muscle-invasive bladder cancer.

Andrea necchiSalute san raffaele universityScientific instituteGenitourinary medical oncologyRaffaele hospitalVita salute san raffaele universityBacillus calmette guHase 2b sunrise 1 trial nct04640623Tar 200Bacillus calmette guérin bcg unresponsiveHigh riskNon muscle invasive bladder cancer

First trial of base editing in humans lowers cholesterol — but raises safety concerns

Super-precise gene-editing approach switches off a gene in the liver that regulates ‘bad’ cholesterol. Super-precise gene-editing approach switches off a gene in the liver that regulates ‘bad’ cholesterol.

United statesNew zealandUnited kingdomSekar kathiresanMichael torresLuigi naldiniLos angelesKarol watsonDavid liu at harvard university in cambridgeAmerican heart associationDrug administrationSteve gschmeissner science photo librarySalute san raffaele universityUniversity of pittsburghUniversity of californiaScience photo